Sponsor Testimonials

At UCI Health, we partner with clinical trial sponsors like you with a shared commitment to improving health for patients. Hear from our clinical trial sponsor partners about their experience working with our clinical trials team.

CTI sponsor
Jacob Schlarman
Clinical project manager of CTI Clinical Trial and Consulting Services

Jacob Schlarman shared his testimonial about the Aviptadil COVID-19 study with the UCI Health team:

"I wanted to send over a quick note of appreciation to your team. It has been a joy working with them throughout the hectic process of starting up our COVID-19 study.

Each person from the UC Irvine team that we’ve interacted with has been nothing but positive, flexible and understanding of our common goals. Clear examples would be [the regulatory staff's] flexibility with the recent protocol changes and unending document requests, [one start-up team member] stepping in for another to finalize the budget on Friday evening, or all folks scrambling to schedule the SIV in multiple portions.

For what it’s worth, you have a great team and, surely, much of that ties back to your all’s leadership.”

Jacob Schlarman shared his testimonial about the Aviptadil COVID-19 study with the UCI Health team:

"I wanted to send over a quick note of appreciation to your team. It has been a joy working with them throughout the hectic process of starting up our COVID-19 study.

Each person from the UC Irvine team that we’ve interacted with has been nothing but positive, flexible and understanding of our common goals. Clear examples would be [the regulatory staff's] flexibility with the recent protocol changes and unending document requests, [one start-up team member] stepping in for another to finalize the budget on Friday evening, or all folks scrambling to schedule the SIV in multiple portions.

For what it’s worth, you have a great team and, surely, much of that ties back to your all’s leadership.”

NeuroRx sponsor
Robert Besthof
NeuroRx’s chief commercial officer and head of operations

NeuroRx Inc. led the Aviptadil clinical trial at UCI Health. Robert Besthof shared his testimonial with the UCI Health clinical trials team:

"Aside from the clinical excellence, one of the many aspects that attracted us to your site is your stewardship and sense of urgency. I recall you pushing me so nicely in our first conversations to move fast, and you and I were negotiating on terms and discussing the protocol while the confidentiality agreement had not been signed, which is completely appropriate with the current times.

This week, I learned that the brother of one of my best friends died of COVID-19. He was a cardiologist/intensivist [in his] mid-60s, [with] no other known risk factors. Clearly, and on a very personal level, our sense of mission and urgency is indomitable.

Other sites have adopted the new protocol and are dosing as we speak. Obviously, the patient situation is different from geography to geography, but with the new protocol active at your site, new possibilities have opened up.

Our quest is to help patients — and we know that this study is in great hands with the team at the University of California, Irvine.

Wishing everybody good health, and especially those taking care of patients.

Thank you for the partnership.”

NeuroRx Inc. led the Aviptadil clinical trial at UCI Health. Robert Besthof shared his testimonial with the UCI Health clinical trials team:

"Aside from the clinical excellence, one of the many aspects that attracted us to your site is your stewardship and sense of urgency. I recall you pushing me so nicely in our first conversations to move fast, and you and I were negotiating on terms and discussing the protocol while the confidentiality agreement had not been signed, which is completely appropriate with the current times.

This week, I learned that the brother of one of my best friends died of COVID-19. He was a cardiologist/intensivist [in his] mid-60s, [with] no other known risk factors. Clearly, and on a very personal level, our sense of mission and urgency is indomitable.

Other sites have adopted the new protocol and are dosing as we speak. Obviously, the patient situation is different from geography to geography, but with the new protocol active at your site, new possibilities have opened up.

Our quest is to help patients — and we know that this study is in great hands with the team at the University of California, Irvine.

Wishing everybody good health, and especially those taking care of patients.

Thank you for the partnership.”

Contact Our Business Development Specialist

Thank you for your interest with our team.

One of our specialists will be in contact with you soon.

Privacy Policy

University of California, Irvine - Study Information Sheet

UCI Center for Clinical Research Potential Participant Database

Lead Researcher
Maheswari Senthil, MD
UCI Center for Clinical Research

In the instance of parental permission, “You” refers to “Your child.”

  • Please read the information below and ask questions about anything that you do not understand. A
    researcher listed above will be available to answer your questions.
  • You are being asked to participate in a clinical research potential participant database to identify
    potential clinical research studies you may be eligible for. Participation in this database is voluntary.
    You may choose to skip any question. You may refuse to participate or discontinue your involvement
    at any time without penalty or loss of benefits. You are free to withdraw from this database at any
    time. If you decide to withdraw from this database you should notify the research team
    immediately    .
  • You are eligible to participate in this study if you may be interested in participating in a research trial at UCI Health
  • We would like to interview you to learn more about your eligibility for current clinical research studies at UCI. The interview will last about 5-30 minutes, depending on the extent of your medical history.
  • Possible risks/discomforts associated with the database are hearing about potential clinical research studies that may not be of interest to you, invasion of your privacy, or a potential breach of confidentiality.
  • There are no direct benefits from participation in the database. However, this database may help inform you on clinical research studies that you may be eligible for. Participation in UCI clinical research studies help us gain important data and knowledge that may lead to improved treatment options for people with similar conditions to you in the future.
  • There are no alternative procedures available. The only alternative is not to participate in this study.
  • There is no compensation for your participation in this database.
  • There is no cost to you for participation in this database.
  • All information collected will be stored confidentially in a world-class securely-hosted application, “RealTime CTMS,” with robust data protections and encryption. This application has HIPAA compliant architecture and application rules to ensure data privacy and regulatory compliance.
  • Researchers will use your information to assess your eligibility for current and future clinical research studies at UCI. You may opt out at any time.
  • The research team, authorized UCI personnel, and regulatory entities, may have access to your study records to protect your safety and welfare.
  • While the research team will make every effort to keep your personal information confidential, it is possible that an unauthorized person might see it. We cannot guarantee total privacy.
  • Future Research Use
    Researchers will use your information to conduct this study. Once the study is done using your information, we may share them with other researchers so they can use them for other studies in the future. We will not share your name or any other private identifiable information that would let the researchers know who you are. We will not ask you for additional permission to share this de-identified information
  • Data Retention - In accordance with UC Office of the President policy, information will be retained for 10 years after the end of the calendar year in which the research is completed.
  • If, during the course of this study, significant new information becomes available that may relate to your willingness to continue to participate, this information will be provided to you by the research team listed at the top of the form.
  • If you have any comments, concerns, or questions regarding the conduct of this research please contact the researchers listed at the top of this form
  • Please contact the UCI Institutional Review Board by phone, (949) 824-8170, by e-mail at IRB@research.uci.edu or at 160 Aldrich Hall, Irvine, CA 92697-7600 if you are unable to reach the researchers listed at the top of the form and have general questions; have concerns or complaints about the research; have questions about your rights as a research subject; or have general comments or suggestions.
What is an IRB? An Institutional Review Board (IRB) is a committee made up of scientists and nonscientists. The IRB’s role is to protect the rights and welfare of human subjects involved in research. The IRB also assures that the research complies with applicable regulations, laws, and institutional policies. UCI